Ameriprise’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63M Sell
34,124
-145,131
-81% -$10.6M ﹤0.01% 2930
2026
Q1
$11.7M Buy
179,255
+4,090
+2% +$304K ﹤0.01% 1804
2025
Q4
$13.9M Buy
175,165
+84,025
+92% +$6.44M ﹤0.01% 1668
2025
Q3
$6.65M Sell
91,140
-1,900
-2% -$139K ﹤0.01% 2209
2025
Q2
$7.06M Sell
93,040
-3,521
-4% -$249K ﹤0.01% 2085
2025
Q1
$7.34M Buy
96,561
+20,687
+27% +$1.54M ﹤0.01% 2003
2024
Q4
$5.02M Buy
75,874
+9,776
+15% +$684K ﹤0.01% 2347
2024
Q3
$4.61M Sell
66,098
-23,472
-26% -$1.41M ﹤0.01% 2427
2024
Q2
$4.74M Buy
+89,570
New +$5.44M ﹤0.01% 2355

Other funds holding SOLV

Ameriprise's SOLV Position: Q2 2026 in Review

Ameriprise reduced its Solventum (SOLV) stake by 81% in Q2 2026, selling an estimated $10.6M and leaving 34,124 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2930.

Ameriprise first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $13.9M in Q4 2025. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Ameriprise held 34,124 shares of Solventum worth $2.63M as of Q2 2026.
  • Ameriprise sold 145,131 Solventum shares in Q2 2026, an estimated $10.6M.
  • Solventum made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2930 holding.
  • Ameriprise first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Ameriprise's Solventum position peaked at $13.9M in Q4 2025.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.